Household Healthcare Sector

Adagene

Market Cap: US$73.5m

A clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People’s Republic of China.

Syntara

Market Cap: AU$113.7m

Operates as a clinical-stage drug development company that focuses on blood-related cancers in Australia.

ESSA Pharma

Market Cap: US$73.2m

A clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer.

Seres Therapeutics

Market Cap: US$72.0m

A clinical-stage company, focuses on developing biotherapeutics for serious diseases.

Surrozen

Market Cap: US$71.9m

A biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair.

Alcidion Group

Market Cap: AU$111.5m

Engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom.

Unicycive Therapeutics

Market Cap: US$71.8m

A clinical-stage biotechnology company, identifies, develops, and commercializes therapies to address unmet medical needs in the United States.

Austco Healthcare

Market Cap: AU$111.0m

Operates as provider of healthcare communication solutions in Australia, New Zealand, Asia, Europe, and North America.

Nuo Therapeutics

Market Cap: US$71.2m

Operates as a regenerative therapies company that develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States.

EDAP TMS

Market Cap: US$71.0m

Develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally.

Adlai Nortye

Market Cap: US$69.7m

A clinical-stage biotechnology company, engages in the research and development of pharmaceutical products.

BeyondSpring

Market Cap: US$69.5m

A clinical stage biopharmaceutical company, focuses on the development of cancer therapies.

Medicenna Therapeutics

Market Cap: CA$95.1m

An immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases.

TScan Therapeutics

Market Cap: US$68.5m

A clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States.

Telomir Pharmaceuticals

Market Cap: US$68.2m

A pre-clinical stage biopharmaceutical company, focuses on developing pharmaceutical products for reversal of oxidative stress, cellular protection, and regulatory mechanism.

Vivani Medical

Market Cap: US$68.1m

A clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases.

Clearside Biomedical

Market Cap: US$67.9m

A biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space.

IO Biotech

Market Cap: US$67.9m

A clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform.

MediciNova

Market Cap: US$67.2m

A biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States.

Pheton Holdings

Market Cap: US$67.1m

A healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy.

InspireMD

Market Cap: US$67.1m

A medical device company, focuses on the development and commercialization of products for the treatment of carotid artery and other vascular diseases in Europe, Latin America, the Middle East, and the Asia Pacific.

Forian

Market Cap: US$66.8m

Provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the life science, healthcare, and financial services industries.

Zura Bio

Market Cap: US$66.2m

A clinical-stage biotechnology company, develops medicines for immune and inflammatory disorders in the United States.

vTv Therapeutics

Market Cap: US$66.2m

A clinical stage biopharmaceutical company, focuses on the development of orally administered treatments for metabolic and inflammatory diseases.

enVVeno Medical

Market Cap: US$66.1m

A clinical-stage medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease.

Jushi Holdings

Market Cap: US$65.8m

A vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for the medical and adult-use markets in the United States.

Assertio Holdings

Market Cap: US$65.7m

A pharmaceutical company, provides various products to patients in the United States.

Argenica Therapeutics

Market Cap: AU$101.2m

A biotechnology company, engages in the research and development of neuroprotective therapeutic drug in Australia.

SDI

Market Cap: AU$101.0m

Engages in the research and development, manufacture, and marketing of dental restorative materials, whitening systems, and other dental materials in Australia, Europe, the United States, and Brazil.

EDX Medical Group

Market Cap: UK£48.5m

Engages in developing a range of diagnostics testing solutions in the United Kingdom.

Alterity Therapeutics

Market Cap: AU$100.4m

Engages in the research and development of therapeutic drugs to treat Alzheimer’s disease, Huntington disease, Parkinson’s disease, and other neurological disorders in Australia.

Optiscan Imaging

Market Cap: AU$100.2m

Engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Australia, Germany, China, and the United States.

Exicure

Market Cap: US$64.4m

Does not have significant operations.

Acumen Pharmaceuticals

Market Cap: US$64.2m

A clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer’s disease.

Vita Life Sciences

Market Cap: AU$99.3m

A healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China.

Citius Oncology

Market Cap: US$63.7m

Focuses on the development of novel targeted oncology therapies.